ZA

Zaheer Ahmed Shaik

Active Director Managing Director DIN 11188550
DIN 11188550 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Zaheer Ahmed Shaik

Data last updated:

Zaheer Ahmed Shaik is a Managing Director at Moleculus Medtech Private Limited (since 2025) and Designated Partner at Dataprix Technologies Llp (since 2025).

DIN 11188550
Primary Designation Managing Director
First Appointment 07 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Moleculus Medtech Private Limited U85303TS2025PTC202888
Managing Director26 Aug 20252025Active
Designated Partner07 Jul 20252025Active

Board colleagues of Zaheer Ahmed Shaik

Directorship timeline

Open interactive timeline →
Moleculus Medtech Private Limited
Dataprix Technologies Llp
Premium access

Shareholding and investment profile for Zaheer Ahmed Shaik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zaheer Ahmed Shaik

Zaheer Ahmed Shaik currently holds 2 directorships: Moleculus Medtech Private Limited (Managing Director, since 26 Aug 2025); Dataprix Technologies Llp (Designated Partner, since 07 Jul 2025).

Zaheer Ahmed Shaik was first appointed on 07 Jul 2025 as Designated Partner at Dataprix Technologies Llp.

The current boards of Zaheer Ahmed Shaik's companies include Shaik Naveed Ahmed (Moleculus Medtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available